Transcriptional control of human p53-regulated genes

Cited by (1,000)

Items 601–700 of 1,000

1. Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells
   Yunxia Li, Xin Chen, Wei He, Shuyue Xia, Xiaochuan Jiang, Xiaoyang Li, Jiayu Bai, Nan Li, Lei Chen, Biao Yang · 2020 · Nutrition and Cancer
2. p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo
   Sydney M. Moyer, Amanda R. Wasylishen, Yuan Qi, Natalie Wall Fowlkes, Xiaoping Su, Guillermina Lozano · 2020 · Proceedings of the National Academy of Sciences
3. Characterization and Anticancer Activity of Biosynthesized Au/Cellulose Nanocomposite from Chlorella vulgaris
   Ragaa A. Hamouda, Ahmed I. Abd El Maksoud, Madonna Wageed, Amenah Saud Alotaibi, Dalia Elebeedy, Hany Khalil, Amr Hassan, Asmaa Abdella · 2021 · Polymers
4. Vpr-Binding Protein Antagonizes p53-Mediated Transcription via Direct Interaction with H3 Tail
   Kyunghwan Kim, Kyu Heo, Jongkyu Choi, Sarah Jackson, Hyun‐Jung Kim, Yue Xiong, Woojin An · 2011 · Molecular and Cellular Biology
5. New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
   Gang Guo, Yan Ru Cui · 2015 · Journal for ImmunoTherapy of Cancer
6. How do transcription factors select specific binding sites in the genome?
   Yongping Pan, Chung‐Jung Tsai, Buyong Ma, Ruth Nussinov · 2009 · Nature Structural & Molecular Biology
7. Probing the Functional Impact of Sequence Variation on p53-DNA Interactions Using a Novel Microsphere Assay for Protein-DNA Binding with Human Cell Extracts
   Maher Noureddine, Daniel Menéndez, Michelle R. Campbell, Omari J. Bandele, Monica M. Horvath, Xuting Wang, Gary S. Pittman, Brian N. Chorley, Michael A. Resnick, Douglas A. Bell · 2009 · PLoS Genetics
8. Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule
   Tae‐Wook Kang, Soon Won Choi, Se‐Ran Yang, Tae–Hoon Shin, Hyung‐Sik Kim, Kyung–Rok Yu, In‐Sun Hong, Seonggu Ro, Joong Myung Cho, Kyung‐Sun Kang · 2014 · Scientific Reports
9. RNAi Screen Indicates Widespread Biological Function for Human Natural Antisense Transcripts
   Mohammad Ali Faghihi, Jannet Kocerha, Farzaneh Modarresi, Pär G. Engström, Alistair M. Chalk, Shaun P. Brothers, Eric Koesema, Georges St. Laurent, Claes Wahlestedt · 2010 · PLoS ONE
10. TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma
    Mariano Francesco Caratozzolo, Alessio Valletti, Margherita Gigante, Italia Aiello, Francesca Mastropasqua, Flaviana Marzano, Pasquale Ditonno, Giuseppe Carrieri, Hélène Simonnet, Anna Maria D’Erchia et al. · 2014 · Oncotarget
11. Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models
    Jennifer Robinson Diamond, S. Gail Eckhardt, Aik Choon Tan, Timothy P. Newton, Heather Marie Selby, Kelsey L. Brunkow, Maria I. Kachaeva, Marileila Varella‐Garcia, Todd M. Pitts, Mark Robert Bray et al. · 2012 · Clinical Cancer Research
12. Post‐translational control of transcription factors: methylation ranks highly
    Simon Mark Carr, Alice Poppy Roworth, Cheryl Siew Choo Chan, Nicholas Barrie La Thangue · 2015 · FEBS Journal
13. Immunohistochemistry should undergo robust validation equivalent to that of molecular diagnostics
    Kelly Elliott, Stephen McQuaid, Manuel Salto‐Tellez, Perry Maxwell · 2015 · Journal of Clinical Pathology
14. MicroRNA Cancer Regulation
    Ulf Schmitz, Olaf Wolkenhauer, Julio Vera · 2013 · Advances in experimental medicine and biology
15. Cellular Senescence, Neurological Function, and Redox State
    Luis Ángel Maciel-Barón, Daniel Moreno-Blas, Sandra Lizbeth Morales-Rosales, Viridiana Yazmín González‐Puertos, Norma Edith López‐Díazguerrero, Claudio A. Torres, Susana Castro‐Obregón, Mina Königsberg · 2017 · Antioxidants and Redox Signaling
16. Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
    Urszula Lucja McClurg, Nay C. T. H. Chit, Mahsa Azizyan, Joanne Edwards, Arash Nabbi, Karl T. Riabowol, Sirintra Nakjang, Stuart R. McCracken, Craig N. Robson · 2018 · Oncogene
17. New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins
    Dmitrij Golovenko, Bastian Bräuning, Pratik Vyas, Tali E. Haran, H. Rozenberg, Zippora Shakked · 2018 · Structure
18. p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress
    Zhenlin Yang, Daniela Kenzelmann Brož, William L Noderer, Joshua P. Ferreira, K. Wesley Overton, Sabrina L. Spencer, Tobias Meyer, Stephen J. Tapscott, Laura Donatella Attardi, Clifford L. Wang · 2014 · Cell Death and Differentiation
19. Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities
    Sangeeta Kumari, Vikas Sharma, Rahul Tiwari, Jay Prakash Maurya, Bharat Bhusan Subudhi, Dhirodatta Senapati · 2022 · European Journal of Pharmacology
20. Phase separation of p53 induced by its unstructured basic region and prevented by oncogenic mutations in tetramerization domain
    Chen Chen, Gaohong Fu, Quanqiang Guo, Song Xue, Shizhong Luo · 2022 · International Journal of Biological Macromolecules
21. TP53 Mutants in the Tower of Babel of Cancer Progression
    Alessandra Bisio, Yari Ciribilli, Gilberto Fronza, Alberto Inga, Paola Monti · 2014 · Human Mutation
22. MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice
    Stephanie Grabow, Alex R. D. Delbridge, Liz J. Valente, Andreas Strasser · 2014 · Blood
23. Xiao-Xu-Ming decoction preserves mitochondrial integrity and reduces apoptosis after focal cerebral ischemia and reperfusion via the mitochondrial p53 pathway
    Rui Lan, Yong Zhang, Jun Yong Xiang, Wen Zhang, Guohua Wang, Wenwei Li, Lili Xu, Dingfang Cai · 2013 · Journal of Ethnopharmacology
24. The impact of post-transcriptional regulation in the p53 network
    J. A. Freeman, Joaquin Maximiliano Espinosa · 2012 · Briefings in Functional Genomics
25. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1
    Diana G. Wright, Claire Marchal, Kimson Hoang, John A. Ankney, Stephanie T. Nguyen, Amanda W. Rushing, Nicholas J. Polakowski, Benoît Miotto, Isabelle Lemasson · 2015 · Oncotarget
26. Diverse p53/DNA binding modes expand the repertoire of p53 response elements
    Pratik Vyas, Itai Beno, Zhiqun Xi, Yan Stein, Dmitrij Golovenko, Naama Kessler, Varda Rotter, Zippora Shakked, Tali E. Haran · 2017 · Proceedings of the National Academy of Sciences
27. Recent Advances in Peptide-Based Approaches for Cancer Treatment
    Anne C. Conibear, Alanca Schmid, Meder Kamalov, Christian F. W. Becker, Claudia Bello · 2017 · Current Medicinal Chemistry
28. bHLH–PAS Proteins: Their Structure and Intrinsic Disorder
    Marta Kolonko, Beata Greb‐Markiewicz · 2019 · International Journal of Molecular Sciences
29. Cytotoxic Activity of Organotin(IV) Derivatives with Triazolopyrimidine Containing Exocyclic Oxygen Atoms
    Alessandro Attanzio, Simone D’Agostino, Rosalia Busà, Anna Frazzitta, Simona Rubino, Maria Assunta Girasolo, Piera Sabatino, Luisa Tesoriere · 2020 · Molecules
30. Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy
    David L. Murray, Razmik Mirzayans · 2020 · International Journal of Molecular Sciences
31. Proteins selectively killing tumor cells
    Mathieu H. M. Noteborn · 2009 · European Journal of Pharmacology
32. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family
    Schilling, Tobias, Schleithoff, Elisa Schulze, Kairat, Astrid, Melino, Gerry, Stremmel, Wolfgang, Oren, Moshe, Krammer, Peter H., Müller, Martina · 2009 · Biochemical and Biophysical Research Communications
33. TRIMming p53’s anticancer activity
    Elabd, S, Meroni, G, Blattner, C · 2016 · Oncogene
34. The Circadian Gene Per1 Plays an Important Role in Radiation-Induced Apoptosis and DNA Damage in Glioma
    Ling Zhu, Qunli Wang, Yi Hu, Fan Wang · 2019 · Asian Pacific Journal of Cancer Prevention
35. The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression
    Nina Fenouille, Guillaume Robert, Mélanie Tichet, Alexandre Puissant, Maeva Dufies, Stéphane Rocchi, Jean Paul Ortonne, Marcel Deckert, Robert Ballotti, Sophie Tartare‐Deckert · 2010 · Pigment Cell & Melanoma Research
36. Rotational positioning of nucleosomes facilitates selective binding of p53 to response elements associated with cell cycle arrest
    Feng Cui, Victor B. Zhurkin · 2013 · Nucleic Acids Research
37. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts
    Jill E. Kucab, Harry VAN STEEG, Mirjam Luijten, Heinz H. Schmeiser, Paul A. White, David H. Phillips, Volker Manfred Arlt · 2015 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
38. apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53
    Osnat Ashur‐Fabian, Adi Har‐Zahav, Aviv Shaish, Hila Wiener Amram, Ofer Margalit, Orly Weizer‐Stern, Dan Dominissini, Dror Harats, Ninette Amariglio, Gideon Rechavi · 2010 · Cell Cycle
39. Differential Control of Notch1 Gene Transcription by Klf4 and Sp3 Transcription Factors in Normal versus Cancer-Derived Keratinocytes
    Chiara Lambertini, Serafino Pantano, Gian Paolo Dotto · 2010 · PLoS ONE
40. Circadian Proteins and Genotoxic Stress Response
    Marina P. Antoch, Roman V. Kondratov · 2010 · Circulation Research
41. p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
    Lindi Chen, Deborah A. Tweddle · 2012 · Frontiers in Oncology
42. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
    Yari Ciribilli, Paola Monti, Alessandra Bisio, H. Thien Nguyen, Abdul Samath Ethayathulla, A. Ramos, Giorgia Foggetti, Paola Menichini, Daniel Menéndez, Michael A. Resnick et al. · 2013 · Nucleic Acids Research
43. Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death
    Ludger Hauck, Shanna Stanley-Hasnain, Amelia Fung, Daniela Grothe, Vivek Rao, Tak W. Mak, Filio Billia · 2017 · PLoS ONE
44. The p53 Codon 72 Polymorphism (rs1042522) Is Associated with Proliferative Vitreoretinopathy
    Salvador Pastor‐Idoate, Irene Rodríguez‐Hernández, Jimena Rojas, Itziar Fernández, María Teresa García-Gutiérrez, José M. Ruiz‐Moreno, Amândio Rocha‐Sousa, Yashin Ramkissoon, Steven Harsum, Robert Edward MacLaren et al. · 2012 · Ophthalmology
45. Cabin1 restrains p53 activity on chromatin
    Hyonchol Jang, Soo‐Youn Choi, Eun‐Jung Cho, Hong‐Duk Youn · 2009 · Nature Structural & Molecular Biology
46. PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
    Lyndsay Davies, David G. Spiller, Michael White, Ian Grierson, Luminita Paraoan · 2011 · Cell Death and Disease
47. BRCA1 deficiency in skin epidermis leads to selective loss of hair follicle stem cells and their progeny
    Sotiropoulou, Panagiota A., Karambelas, Andrea E., Debaugnies, Maud, Candi, Aurelie, Bouwman, Peter, Moers, Virginie, Revenco, Tatiana, Rocha, Ana Sofia, Sekiguchi, Kiyotoshi, Jonkers, Jos et al. · 2013 · Genes & Development
48. Box–Behnken design of thermo-responsive nano-liposomes loaded with a platinum( iv ) anticancer complex: evaluation of cytotoxicity and apoptotic pathways in triple negative breast cancer cells
    Nada K. Sedky, Maria Braoudaki, Noha Khalil Mahdy, Kenzy Amin, Iten M. Fawzy, Eleni Κ. Efthimiadou, Rana Ahmed Youness, Sherif Ashraf Fahmy · 2023 · Nanoscale Advances
49. p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP
    Yingdan Huang, Xiong Chen, Chunmeng Wang, Jun Deng, Zhixiang Zuo, Huijing Wu, Jianping Xiong, Xiaohua Wu, Hua Lu, Qian Hao et al. · 2023 · Cell Reports
50. Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors
    Mathieu Dalvai, Odile Mondésert, Jean‐Christophe Bourdon, Bernard Ducommun, Christine Dozier · 2011 · Oncogene
51. p53 and Ceramide as Collaborators in the Stress Response
    Rouba Hage‐Sleiman, Maria O. Esmerian, Hadile Kobeissy, Ghassan S. Dbaibo · 2013 · International Journal of Molecular Sciences
52. p53 Directly Represses Id2 to Inhibit the Proliferation of Neural Progenitor Cells
    Brenton R. Paolella, Matthew C. Havrda, Akio Mantani, Christina M. Wray, Zhonghua Zhang, Mark A. Israel · 2011 · Stem Cells
53. Epirubicin Upregulates UDP Glucuronosyltransferase 2B7 Expression in Liver Cancer Cells via the p53 Pathway
    Dong Gui Hu, Anne Rogers, Peter I. Mackenzie · 2014 · Molecular Pharmacology
54. SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells
    Idha Kurtsdotter, Danijal Topcic, Alexandra Karlén, Bhumica Singla, Daniel W. Hagey, Maria Bergsland, Peter Siesjö, Monica Nistér, Joseph W. Carlson, Véronique Lefebvre et al. · 2017 · Cancer Research
55. Transcription factors: Time to deliver
    Alexey V. Ulasov, Andrey A. Rosenkranz, Alexander S. Sobolev · 2017 · Journal of Controlled Release
56. An Ancestral Allele of Pyrroline-5-carboxylate synthase1 Promotes Proline Accumulation and Drought Adaptation in Cultivated Barley
    Shumaila Muzammil, Asis Shrestha, Said Dadshani, Klaus Pillen, Shahid Siddique, Jens Léon, Ali Ahmad Naz · 2018 · PLANT PHYSIOLOGY
57. Conformational stability and dynamics of the cancer‐associated isoform Δ133p53β are modulated by p53 peptides and p53‐specific DNA
    Jiangtao Lei, Ruxi Qi, Yegen Tang, Wenning Wang, Guanghong Wei, Ruth Nussinov, Buyong Ma · 2018 · The FASEB Journal
58. USP 10 regulates Musashi‐2 stability via deubiquitination and promotes tumour proliferation in colon cancer
    Siwen Ouyang, Ting‐ting Liu, Xi-Sheng Liu, Fuxiang Zhu, Fangming Zhu, Xue-Ni Liu, Zhihai Peng · 2019 · FEBS Letters
59. Transcriptional regulation of Rho GTPase signaling
    Daniel R. Croft, Michael F. Olson · 2011 · Transcription
60. The nucleolar GTP-binding proteins Gnl2 and nucleostemin are required for retinal neurogenesis in developing zebrafish
    Judith T.M.L. Paridaen, Esther Janson, Kagistia Hana Utami, Tamara C. Pereboom, Paul Essers, Carina van Rooijen, Danica Živković, Alyson W. MacInnes · 2011 · Developmental Biology
61. Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing
    Eiji Iwama, Kazuko Sakai, Koichi Azuma, Daijiro Harada, Kaname Nosaki, Katsuyuki Hotta, Makoto Nishio, Takayasu Kurata, Tatsuro Fukuhara, Hiroaki Akamatsu et al. · 2018 · Cancer Science
62. MIF Family Members Cooperatively Inhibit p53 Expression and Activity
    Stephanie Erin Brock, Beatriz E. Rendon, Dan Xin, Kavitha Yaddanapudi, Robert A. Mitchell · 2014 · PLoS ONE
63. OTX1 expression in breast cancer is regulated by p53
    Alessandro Terrinoni, Ilaria Stefania Pagani, Ileana Zucchi, Anna Maria Chiaravalli, Valeria Serra, Francesca Angela Rovera, Silvia Maria Sirchia, Gianlorenzo Dionigi, Monica Rosa Miozzo, Annalisa Frattini et al. · 2011 · Oncogene
64. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency
    L Cheng, Zong‐Guang Zhou, Andrea Flesken‐Nikitin, Ilya Toshkov, W Wang, Jordi Camps, Thomas Ried, A Y Nikitin · 2010 · Oncogene
65. p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
    Virginia Andreotti, Yari Ciribilli, Paola Monti, Alessandra Bisio, Mattia Lion, Jennifer Jordan, Gilberto Fronza, Paola Menichini, Michael A. Resnick, Alberto Inga · 2011 · PLoS ONE
66. A nanobody modulates the p53 transcriptional program without perturbing its functional architecture
    Jonas Bethuyne, Steven De Gieter, Olivier Zwaenepoel, Abel Garcia‐Pino, Kaat Durinck, Adriaan Verhelle, Gholamreza Hassanzadeh‐Ghassabeh, Frank Speleman, Remy Loris, Jan Gettemans · 2014 · Nucleic Acids Research
67. Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
    Massimo Pancione, Nicola Rosario Forte, Alessandra Fucci, Lina Sabatino, Antonio Febbraro, Arturo Di Blasi, Bruno Daniele, Domenico Parente, Vittorio Colantuoni · 2010 · Human Pathology
68. DECOD: fast and accurate discriminative DNA motif finding
    Peter M. Huggins, Shan Zhong, Idit Shiff, Rachel Beckerman, Oleg Laptenko, Carol L. Prives, Marcel H. Schulz, Itamar Simon, Ziv Bar‐Joseph · 2011 · Bioinformatics
69. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells
    Liz J. Valente, Brandon J. Aubrey, Marco J. Herold, Gemma L. Kelly, Lina Happo, Clare L. Scott, Andrea Newbold, Ricky W. Johnstone, David C.S. Huang, Lyubomir T. Vassilev et al. · 2016 · Cell Reports
70. The Hippo pathway, p53 and cholesterol
    Yael Aylon, Moshe Oren · 2016 · Cell Cycle
71. Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53
    Wei Peng, Changling Hu, Zhiheng Shu, Ting Han, Luping Qin, Chengjian Zheng · 2015 · Phytomedicine
72. Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence
    Durai Sundar, Yue Yu, Shashank Prakash Katiyar, Jayarani Fatimah Putri, Jaspreet Kaur Dhanjal, Jia Wang, Anissa Nofita Sari, Evangelos Kolettas, Sunil C. Kaul, Renu Wadhwa · 2019 · Journal of Experimental & Clinical Cancer Research
73. LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma
    Young-Ah Kim, Kwan‐Kyu Park, Sun-Jae Lee · 2020 · International Journal of Molecular Sciences
74. MK2 regulates the early stages of skin tumor promotion
    Claus Johansen, Christian Vestergaard, Knud Kragballe, George A. Kollias, Matthias Gaestel, Lars Iversen · 2009 · Carcinogenesis
75. Keratinocyte Stem Cells but Not Melanocyte Stem Cells Are the Primary Target for Radiation-Induced Hair Graying
    Aoki, Hitomi, Hara, Akira, Motohashi, Tsutomu, Kunisada, Takahiro · 2013 · Journal of Investigative Dermatology
76. Transcriptional correlates of the pathological phenotype in a Huntington’s disease mouse model
    Andrea Gallardo-Orihuela, Irati Hervás-Corpión, Carmen Hierro‐Bujalance, Daniel Sanchez-Sotano, Gema Jiménez‐Gómez, Francisco Mora‐López, Antonio Campos‐Caro, Mónica Garcı́a-Alloza, Luis Miguel Valor · 2019 · Scientific Reports
77. Aluminum Oxide and Zinc Oxide Induced Nanotoxicity in Rat Brain, Heart, and Lung
    Mokhtar Ibrahim Yousef, Shubhadeep Roychoudhury, K JAFAAR, Petr Sláma, Kavindra Kumar Kesari, Maher Abd EL-Nabi Kamel · 2022 · Physiological Research
78. Tumor Suppressor Protein p53 Recruits Human Sin3B/HDAC1 Complex for Down-Regulation of Its Target Promoters in Response to Genotoxic Stress
    Nidhi Bansal, Rama Kadamb, Shilpi Mittal, Leena Vig, Raisha Sharma, Bilikere Srinivasa Rao Dwarakanath, Daman Saluja · 2011 · PLoS ONE
79. Dissecting the transcriptional phenotype of ribosomal protein deficiency: implications for Diamond-Blackfan Anemia
    Anna Aspesi, Elisa Pavesi, Elisa Robotti, Rossella Crescitelli, Ilenia Boria, Federica Avondo, Hélène Moniz, Lydie M. Da Costa, Narla Mohandas, Paola Roncaglia et al. · 2014 · Gene
80. Differential Expression of Stress and Immune Response Pathway Transcripts and miRNAs in Normal Human Endothelial Cells Subjected to Fractionated or Single-Dose Radiation
    Sanjeewani T. Palayoor, Molykutty John‐Aryankalayil, Adeola Y. Makinde, Michael T. Falduto, Scott R. Magnuson, C. Norman Coleman · 2014 · Molecular Cancer Research
81. Antiproliferative and apoptosis-induction studies of a metallosurfactant in human breast cancer cell MCF-7
    Anvarbatcha Riyasdeen, Rajendran Senthilkumar, Vaiyapuri Subbarayan Periasamy, Preethy Paul, Bangalore Suresh Srinag, Mohammed Zeeshan, Hanumanthappa Krishnamurthy, Sankaralingam Arunachalam, Mohammad Abdulkader Akbarsha · 2014 · RSC Advances
82. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer
    Han Si, Hai Lü, Xinping Yang, Austin K. Mattox, M Jang, Y. Bian, E Sano, Héctor Viadiu, B. Yan, Christina S. F. Yau et al. · 2016 · Oncogene
83. Thymoquinone and geraniol alleviate cisplatin-induced neurotoxicity in rats through downregulating the p38 MAPK/STAT-1 pathway and oxidative stress
    Mohamed A. Kandeil, Mohamed O. Mahmoud, Abdel‐Razik H. Abdel‐Razik, Safaa B. Gomaa · 2019 · Life Sciences
84. Viral Apoptosis Evasion via the MAPK Pathway by Use of a Host Long Noncoding RNA
    Samantha Barichievy, Jerolen Naidoo, Mikaël Boullé, Janine Scholefield, Suraj P. Parihar, Anna K. Coussens, Frank Brombacher, Alex Sigal, Musa M. Mhlanga · 2018 · Frontiers in Cellular and Infection Microbiology
85. An LTR retrotransposon‐derived lncRNA interacts with RNF169 to promote homologous recombination
    Deng, Bing, Xu, Wenli, Wang, Zelin, Liu, Chang, Lin, Penghui, Li, Bin, Huang, Qiaojuan, Yang, Jianhua, Zhou, Hui, Qu, Lianghu · 2019 · The EMBO Reports
86. Stochastic transcription in the p53‐mediated response to DNA damage is modulated by burst frequency
    Dhana Friedrich, Laura Friedel, Ana Finzel, Andreas Herrmann, Stephan Preibisch, Alexander Loewer · 2019 · Molecular Systems Biology
87. Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
    Juliana Brandstetter Vilar, Markus Christmann, Maja T. Tomicic · 2022 · Cancers
88. Helicobacter pylori bacteria alter the p53 stress response via Erk-HDM2 pathway
    Vikas Bhardwaj, Jennifer M. Noto, Jinxiong Wei, Claudia D. Andl, Wael M. El-Rifai, Richard M. Peek, Alexander I. Zaika · 2015 · Oncotarget
89. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH
    Hwa-Ryeon Kim, Jae‐Seok Roe, Ji‐Eun Lee, In‐Young Hwang, Eun‐Jung Cho, Hong‐Duk Youn · 2012 · Biochemical and Biophysical Research Communications
90. DNA Damage/Repair Management in Cancers
    Jehad F. Alhmoud, John F. Woolley, Ala‐Eddin Al Moustafa, Mohammed Imad Mallei · 2021
91. p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
    Yaxue Zeng, Yojiro Kotake, Xin‐Hai Pei, Matthew D. Smith, Yue Xiong · 2011 · Cancer Research
92. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells
    Emira Ayroldi, Maria Grazia Petrillo, Alessandra Bastianelli, M C Marchetti, Simona Ronchetti, Giuseppe Nocentini, L Ricciotti, Lorenza Cannarile, Carlo Riccardi · 2014 · Cell Death and Differentiation
93. Autophagy and the invisible line between life and death
    Chrisna Swart, André du Toit, Ben Loos · 2016 · European Journal of Cell Biology
94. Methanolic bark extract of Acacia catechu ameliorates benzo(a)pyrene induced lung toxicity by abrogation of oxidative stress, inflammation, and apoptosis in mice
    Ayaz Shahid, Rashid Ali, Nemat Ali, Syed Kazim Hasan, Preeti Barnwal, Shekh Mohammad Afzal, Abul Vafa, Sarwat Sultana · 2016 · Environmental Toxicology
95. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition
    Monika Aggarwal, Rahul Saxena, Nasir Asif, Elizabeth Sinclair, Judy Tan, Idalia M. Cruz, Deborah L. Berry, Bhaskar Kallakury, Quynhchi Pham, Thomas T. Y. Wang et al. · 2019 · Journal of Experimental & Clinical Cancer Research
96. Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations
    Le Li, Xuhua Li, Yiming Tang, Zenghui Lao, Jiangtao Lei, Guanghong Wei · 2020 · Physical Chemistry Chemical Physics
97. Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer
    Arijit Nath, Soham Mitra, Tanuma Mistry, Ranita Pal, Vilas D. Nasare · 2021 · Medical Oncology
98. Mutant p53 subverts p63 control over KLF4 expression in keratinocytes
    Nicoletta Cordani, Silvia Pozzi, E Martynova, Daniele Fanoni, Serena Borrelli, Daniela Alotto, Carlotta Castagnoli, Emilio Berti, M Viganò, Roberto Mantovani · 2010 · Oncogene
99. Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia
    Ulrike Kaindl, M Morak, Craig Portsmouth, A Mecklenbräuker, Max Kauer, Marion Zeginigg, Andishe Attarbaschi, Oskar A. Haas, Renate Panzer‐Grümayer · 2013 · Leukemia
100. Inhibition of MDM2 attenuates neointimal hyperplasia via suppression of vascular proliferation and inflammation
     Toru Hashimoto, Toshihiro Ichiki, Jiro Ikeda, Eriko Narabayashi, Hirohide Matsuura, Ryohei Miyazaki, Keita Inanaga, Kotaro Takeda, Kenji Sunagawa · 2011 · Cardiovascular Research